{"id":"https://openalex.org/W1999546977","doi":"https://doi.org/10.1002/ppul.10290","title":"Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: A phase I feasibility study","display_name":"Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: A phase I feasibility study","alternate_titles":[],"publication_year":2003,"publication_date":"2003-05-08","ids":{"openalex":"https://openalex.org/W1999546977","doi":"https://doi.org/10.1002/ppul.10290","mag":"1999546977","pmid":"https://pubmed.ncbi.nlm.nih.gov/12746939"},"language":"en","primary_location":{"id":"doi:10.1002/ppul.10290","doi":"https://doi.org/10.1002/ppul.10290","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ppul.10290","pdf_url":null,"source":{"id":"https://openalex.org/S144578311","display_name":"Pediatric Pulmonology","issn_l":"1099-0496","issn":["1099-0496","8755-6863"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Pulmonology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1999546977"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014164664","display_name":"H Kollberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]},{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Hans Kollberg","raw_affiliation_strings":["Uppsala CF Center, Department of Women's and Children's Health, University Hospital, Uppsala, Sweden. hans.kollberg@kbh.uu.se","Uppsala CF Center, Department of Women's and Children's Health, University Hospital, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uppsala CF Center, Department of Women's and Children's Health, University Hospital, Uppsala, Sweden. hans.kollberg@kbh.uu.se","institution_ids":["https://openalex.org/I123387679","https://openalex.org/I1342360035"]},{"raw_affiliation_string":"Uppsala CF Center, Department of Women's and Children's Health, University Hospital, Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022707281","display_name":"David Carlander","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Carlander","raw_affiliation_strings":["Division of Clinical Chemistry, Department of Medical Sciences, University Hospital, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Chemistry, Department of Medical Sciences, University Hospital, Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061668266","display_name":"Hanne Vebert Olesen","orcid":"https://orcid.org/0000-0003-4000-210X","observed_orcids":["https://orcid.org/0000-0003-4000-210X"]},"institutions":[{"id":"https://openalex.org/I2802335433","display_name":"Aarhus University Hospital","ror":"https://ror.org/040r8fr65","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802335433"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hanne Olesen","raw_affiliation_strings":["Aarhus University Hospital, Skejby Sygehus, Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aarhus University Hospital, Skejby Sygehus, Aarhus, Denmark","institution_ids":["https://openalex.org/I2802335433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079463717","display_name":"Per\u2010Erik Wej\u00e5ker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Per\u2010Erik Wej\u00e5ker","raw_affiliation_strings":["Division of Clinical Chemistry, Department of Medical Sciences, University Hospital, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Chemistry, Department of Medical Sciences, University Hospital, Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105523599","display_name":"Marie Johannesson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie Johannesson","raw_affiliation_strings":["Uppsala CF Center, Department of Women's and Children's Health, University Hospital, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uppsala CF Center, Department of Women's and Children's Health, University Hospital, Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108435368","display_name":"Anders Larsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anders Larsson","raw_affiliation_strings":["Division of Clinical Chemistry, Department of Medical Sciences, University Hospital, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Chemistry, Department of Medical Sciences, University Hospital, Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5014164664"],"corresponding_institution_ids":["https://openalex.org/I123387679","https://openalex.org/I1342360035"],"apc_list":{"value":4740,"currency":"USD","value_usd":4740},"apc_paid":null,"fwci":2.7321,"has_fulltext":false,"cited_by_count":141,"citation_normalized_percentile":{"value":0.89337416,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"35","issue":"6","first_page":"433","last_page":"440"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10593","display_name":"Bacterial biofilms and quorum sensing","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cystic-fibrosis","display_name":"cystic fibrosis","score":0.8899999856948853},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.9959999918937683},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6510000228881836},{"id":"https://openalex.org/keywords/egg-yolk-antibodies","display_name":"egg yolk antibodies","score":0.7919999957084656},{"id":"https://openalex.org/keywords/igy","display_name":"IgY","score":0.7749999761581421},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.4659999907016754},{"id":"https://openalex.org/keywords/gargling","display_name":"gargling","score":0.675000011920929},{"id":"https://openalex.org/keywords/chronic-bacterial-colonization","display_name":"chronic bacterial colonization","score":0.6039999723434448},{"id":"https://openalex.org/keywords/infection-control","display_name":"infection control","score":0.7110000252723694},{"id":"https://openalex.org/keywords/sputum-culture","display_name":"sputum culture","score":0.6269999742507935},{"id":"https://openalex.org/keywords/antibiotic-alternatives","display_name":"antibiotic alternatives","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8453875780105591},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.7609420418739319},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.7209353446960449},{"id":"https://openalex.org/C2776927270","wikidata":"https://www.wikidata.org/wiki/Q815962","display_name":"Colonization","level":2,"score":0.6916366815567017},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.6527969241142273},{"id":"https://openalex.org/C2776301714","wikidata":"https://www.wikidata.org/wiki/Q259346","display_name":"Sputum","level":3,"score":0.6255928874015808},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5542558431625366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5246800780296326},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.45159339904785156},{"id":"https://openalex.org/C2779912665","wikidata":"https://www.wikidata.org/wiki/Q7581635","display_name":"Sputum culture","level":4,"score":0.4260365962982178},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.396626740694046},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3394146263599396},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.2914111614227295},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.174144446849823},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09740906953811646},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08311092853546143},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true},{"descriptor_ui":"D005240","descriptor_name":"Feasibility Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D013183","descriptor_name":"Sputum","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/ppul.10290","doi":"https://doi.org/10.1002/ppul.10290","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ppul.10290","pdf_url":null,"source":{"id":"https://openalex.org/S144578311","display_name":"Pediatric Pulmonology","issn_l":"1099-0496","issn":["1099-0496","8755-6863"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Pulmonology","raw_type":"journal-article"},{"id":"pmid:12746939","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12746939","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric pulmonology","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.atira.dk:publications/45ff1357-5e9f-4201-ac02-a68681492e82","doi":null,"is_oa":false,"landing_page_url":"https://pure.au.dk/portal/en/publications/45ff1357-5e9f-4201-ac02-a68681492e82","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kollberg, H, Carlander, D, Olesen, H V, Wej\u00e5ker, P-E, Johannesson, M & Larsson, A 2003, 'Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase I feasibility study', Pediatric Pulmonology, vol. 35, no. 6, pp. 433-40. https://doi.org/10.1002/ppul.10290","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320317341","display_name":"Swedish National Board for Industrial and Technical Development","ror":null},{"id":"https://openalex.org/F4320321501","display_name":"Carl Tryggers Stiftelse f\u00f6r Vetenskaplig Forskning","ror":"https://ror.org/048p4fn82"},{"id":"https://openalex.org/F4320322169","display_name":"Hj\u00e4rt-Lungfonden","ror":"https://ror.org/052261q33"},{"id":"https://openalex.org/F4320322315","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691"},{"id":"https://openalex.org/F4320325661","display_name":"Stiftelsen Riksf\u00f6rbundet Cystisk Fibros Forskningsfond","ror":"https://ror.org/027bpvr73"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W185174942","https://openalex.org/W644576092","https://openalex.org/W1622059472","https://openalex.org/W1823712555","https://openalex.org/W1830713452","https://openalex.org/W1900586367","https://openalex.org/W1969697265","https://openalex.org/W1971202778","https://openalex.org/W1973681087","https://openalex.org/W1980004985","https://openalex.org/W2004177219","https://openalex.org/W2004433613","https://openalex.org/W2039599894","https://openalex.org/W2042596893","https://openalex.org/W2053762589","https://openalex.org/W2057499027","https://openalex.org/W2068491305","https://openalex.org/W2068781163","https://openalex.org/W2093178879","https://openalex.org/W2097236051","https://openalex.org/W2101273248","https://openalex.org/W2101667079","https://openalex.org/W2114822864","https://openalex.org/W2125391335","https://openalex.org/W2126561012","https://openalex.org/W2133531226","https://openalex.org/W2146348686","https://openalex.org/W2147064431","https://openalex.org/W2152321550","https://openalex.org/W2155069031","https://openalex.org/W2284952307","https://openalex.org/W2321238843","https://openalex.org/W2406057374","https://openalex.org/W3108176776","https://openalex.org/W4252831606"],"related_works":["https://openalex.org/W2034864264","https://openalex.org/W2015441535","https://openalex.org/W262383095","https://openalex.org/W621503744","https://openalex.org/W644576092","https://openalex.org/W2008181112","https://openalex.org/W2409057264","https://openalex.org/W2803683747","https://openalex.org/W2078577426","https://openalex.org/W7218062646"],"abstract_inverted_index":{"Respiratory":[0],"infection":[1],"is":[2,27],"the":[3,52,68,71,74,81,84,92,127,145,151,154,157,168,171,181,184,216,247],"major":[4],"cause":[5],"of":[6,54,86,94,108,120,198,202,224],"morbidity":[7],"and":[8,73,90,159,200,230],"mortality":[9],"in":[10,22,147],"cystic":[11],"fibrosis":[12],"(CF)":[13],"patients.":[14,25],"Chronic":[15],"Pseudomonas":[16],"aeruginosa":[17],"(PA)":[18],"infections":[19],"ultimately":[20],"occur":[21],"virtually":[23],"all":[24],"It":[26],"impossible":[28],"to":[29,49,59,117,249],"eradicate":[30],"PA":[31,55,76,88,112,136,163,194,252],"when":[32],"a":[33,118],"patient":[34],"has":[35,246],"been":[36],"chronically":[37,206,235],"colonized.":[38],"Immunotherapy":[39],"with":[40,63,101,111,126,135,162,208,237],"specific":[41,64],"egg-yolk":[42],"antibodies":[43],"(IgY)":[44],"may":[45],"be":[46,264],"an":[47,102],"alternative":[48],"antibiotics":[50],"for":[51,167,193,228],"prevention":[53],"infections.":[56],"We":[57],"wanted":[58],"determine":[60],"if":[61],"treatment":[62,82,142],"IgY":[65,245],"can":[66,80],"prolong":[67],"period":[69,155],"between":[70,156],"first":[72,133,158],"second":[75,160],"colonization?":[77,96],"And":[78],"long-term,":[79],"diminish":[83],"number":[85],"positive":[87,192,227],"cultures":[89,191,220],"postpone":[91],"onset":[93],"chronic":[95],"CF":[97],"patients":[98,121,204,233],"gargled":[99],"daily":[100],"IgY-antibody":[103],"preparation,":[104],"purified":[105],"from":[106],"eggs":[107],"hens":[109],"immunized":[110],"bacteria.":[113],"They":[114],"were":[115,213,226],"compared":[116],"group":[119,173,186],"who":[122],"did":[123],"not":[124],"gargle":[125],"preparation.":[128],"Both":[129],"groups":[130],"had":[131,187],"their":[132],"colonization":[134,161,253],"eradicated":[137],"by":[138],"antibiotics.":[139],"The":[140],"basic":[141],"was":[143,164],"essentially":[144],"same":[146],"both":[148],"groups.":[149],"In":[150,180,215],"initial":[152],"study,":[153,183],"significantly":[165],"prolonged":[166,182],"treated":[169,185],"vs.":[170],"control":[172,217],"(Kaplan-Meier":[174],"P":[175],"=":[176],"0.015,":[177],"Breslow":[178],"test).":[179],"only":[188],"2.5":[189],"sputum":[190],"per":[195,221],"100":[196,222],"months":[197,223],"observation,":[199],"none":[201],"these":[203],"became":[205,234],"colonized":[207,236],"PA.":[209,238],"No":[210],"adverse":[211,257],"events":[212],"reported.":[214],"group,":[218],"13.7":[219],"observation":[225],"PA,":[229],"5":[231],"(24%)":[232],"This":[239],"feasibility":[240],"study":[241,262],"shows":[242],"that":[243],"antipseudomonal":[244],"potential":[248],"effectively":[250],"prevent":[251],"without":[254],"any":[255],"severe":[256],"effects.":[258],"A":[259],"phase":[260],"III":[261],"should":[263],"initiated.":[265]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1999546977","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
